ODYYOTCSurgical & Medical Instruments & ApparatusFiscal year ends July 31
Odyssey Health, Inc.
Financials through Q3 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Jun 12, 2026
$0.01−0.00 (-16.25%)
Close on Oct 19, 2026
- Market cap
- $1.25M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Odyssey Health's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Lutz Jonathan D | 7,239,595 | 7.30% | 13G (passive) amendment | Nov 21, 2025 |
| Odyssey Health, Inc. | 511,308 | 16.60% | 13D (active) | Dec 28, 2023 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| John P. Gandolfo – | Jan 10, 2024 | Award | +1,500,000 | $0.09 | $135.00K | 1,738,792 |
| J. Michael Redmond President & CEO, Director | Sep 2, 2022 | Gift | −1,500,000 | $0.16 | $240.00K | 8,500,000 |
| Jacob Ph.D Vanlandingham – | Jun 10, 2022 | Award | +1,000,000 | $0.23 | $230.00K | 9,660,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Odyssey Health, Inc. Stockholder | Jun 13, 2025 | 17,044 | $79.94K | Jun 10, 2025 | Asset Purchase Agreement |